Preventing primary liver cancer: how well are we  faring towards a national hepatitis B strategy?

Awofeso, Niyi

doi:10.5694/j.1326-5377.2008.tb02003.x

Topics

To the Editor: The recent call by Robotin and colleagues for a national strategy to respond to the increasing incidence of hepatitis B and hepatocellular carcinoma (HCC) in Australia1 is timely. I would like to add the following comments.

School of Public Health and Community Medicine, University of New South Wales, Sydney, NSW.

Correspondence: niyi.awofeso@hotmail.com

1. Robotin MC, George J, Supramaniam R, et al. Preventing primary liver cancer: how well are we faring towards a national hepatitis B strategy? Med J Aust 2008; 188: 363-365. <MJA full text>
2. Butler T, Milner L. The 2001 New South Wales inmate health survey. Sydney: NSW Corrections Health Service, 2003.
3. Australian Government Department of Health and Ageing. Vaccination for our mob. Canberra: Commonwealth of Australia, 2006.
4. Amin J. Hepatitis B and C associated cancer and mortality: New South Wales, 1990–2002 [PhD thesis]. Sydney: University of New South Wales, 2006.
5. Yang HI, Lu SN, Liaw YF, et al. Hepatitis B e antigen and the risk of hepatocellular carcinoma. N Engl J Med 2002; 347: 168-174.
6. Holck P, Bulkow L, Snowball M. Serologic and clinical outcomes of 1536 Alaskan natives chronically infected with hepatitis B virus. Ann Intern Med 2001; 135: 759-768.

Online responses are no longer available. Please refer to our instructions for authors page for more information.